{"id":"W2572214220","doi":"10.1016/j.urology.2017.01.006","title":"Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy","year":2017,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nephrectomy; Adjuvant; Placebo; Internal medicine; Oncology; Urology; Kidney disease; Clear cell renal cell carcinoma; Kidney; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00210791,0.0007735349,0.001859796,0.0007610386,0.003200672,0.002901532,0.001836554,0.04642513,0.007097944],"category_scores_gemma":[0.02208637,0.0005933981,0.00134122,0.0008854433,0.002000131,0.002993742,0.001239756,0.03518395,0.004791759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00458116,"about_ca_system_score_gemma":0.004830295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004482559,"about_ca_topic_score_gemma":0.007838348,"domain_scores_codex":[0.9977134,0.000807789,0.00032345,0.0002945708,0.0005476392,0.0003131563],"domain_scores_gemma":[0.9941135,0.003439366,0.0005460178,0.0001172492,0.0008286138,0.0009553455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001117575,0.00003407594,0.0008456899,0.00007768273,0.00002326766,0.002419177,0.00006656074,0.000113576,0.00009511055,0.001109473,0.989921,0.005182767],"study_design_scores_gemma":[0.0005216855,0.0002265466,0.002840285,0.001067439,0.000175722,0.007053112,0.0006911846,0.001433628,0.0004650783,0.01234068,0.9730011,0.0001835987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003827821,0.001087205,0.00004593132,0.9710938,0.02573395,0.00001015128,0.00008234313,0.00001579675,0.001548163],"genre_scores_gemma":[0.006179935,0.001558723,0.0001228032,0.8870261,0.1013438,0.00003756706,0.000073844,0.00002562565,0.003631725],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04642513,"threshold_uncertainty_score":0.03323877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01626866260123924,"score_gpt":0.2416190297224754,"score_spread":0.2253503671212361,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}